ES2128051T3 - Isomero de doble enlace de la equilina, procedente de la isomerizacion acida de la equilina. - Google Patents

Isomero de doble enlace de la equilina, procedente de la isomerizacion acida de la equilina.

Info

Publication number
ES2128051T3
ES2128051T3 ES95915579T ES95915579T ES2128051T3 ES 2128051 T3 ES2128051 T3 ES 2128051T3 ES 95915579 T ES95915579 T ES 95915579T ES 95915579 T ES95915579 T ES 95915579T ES 2128051 T3 ES2128051 T3 ES 2128051T3
Authority
ES
Spain
Prior art keywords
equiline
isomer
double link
acid isomerization
isoestrone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95915579T
Other languages
English (en)
Spanish (es)
Inventor
Frederick Quincy Gemmill Jr
Chester Eugene Orzech
Steven Jay Adelman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Application granted granted Critical
Publication of ES2128051T3 publication Critical patent/ES2128051T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES95915579T 1994-04-08 1995-04-06 Isomero de doble enlace de la equilina, procedente de la isomerizacion acida de la equilina. Expired - Lifetime ES2128051T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/224,849 US5395831A (en) 1994-04-08 1994-04-08 Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone

Publications (1)

Publication Number Publication Date
ES2128051T3 true ES2128051T3 (es) 1999-05-01

Family

ID=22842497

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95915579T Expired - Lifetime ES2128051T3 (es) 1994-04-08 1995-04-06 Isomero de doble enlace de la equilina, procedente de la isomerizacion acida de la equilina.

Country Status (18)

Country Link
US (3) US5395831A (enExample)
EP (1) EP0754190B1 (enExample)
JP (1) JPH09511748A (enExample)
KR (1) KR970702291A (enExample)
CN (1) CN1149298A (enExample)
AT (1) ATE177111T1 (enExample)
AU (1) AU688029B2 (enExample)
CA (1) CA2186486A1 (enExample)
DE (1) DE69508068T2 (enExample)
DK (1) DK0754190T3 (enExample)
ES (1) ES2128051T3 (enExample)
GR (1) GR3030185T3 (enExample)
HU (1) HUT76338A (enExample)
IL (1) IL113178A (enExample)
NZ (1) NZ283951A (enExample)
TW (1) TW314468B (enExample)
WO (1) WO1995027724A1 (enExample)
ZA (1) ZA952771B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
AU7013296A (en) * 1995-08-30 1997-03-19 Eli Lilly And Company N-butylsulfonate esters of estrogens
ZA968873B (en) 1995-11-06 1997-05-28 Akzo Nobel Nv Isomerisation of equillin
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
EP0785212A1 (en) * 1996-01-22 1997-07-23 Laboratoire Theramex New 19-nor-pregnene derivatives
ID18256A (id) * 1996-09-16 1998-03-19 American Home Prod Penggunaan dari 8,9-dehidro estron sebagai estrogen dengan hasil netral pada tingkat prolaktin
IL124213A (en) * 1997-05-02 2004-12-15 Akzo Nobel Nv Sulfation of estrogen mixtures
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
US5866561A (en) * 1997-08-21 1999-02-02 Scimed Life Systems, Inc. Local delivery of estrogen for angiogenesis
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
EP1330467B1 (en) 2000-11-03 2007-05-02 Washington University Modified, hydroxy-substituted aromatic structures having cytoprotective activity
US20020132802A1 (en) * 2000-11-17 2002-09-19 Washington Univeristy Cytoprotective polycyclic compounds
US20030158432A1 (en) * 2002-01-08 2003-08-21 Leonard Thomas W. Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
US6855735B2 (en) 2002-03-20 2005-02-15 Temple University Of The Commonwealth System Of Higher Education Ketamine treatment of restless legs syndrome
WO2003084978A1 (en) * 2002-04-01 2003-10-16 University Of Florida Steroidal quinols as prodrugs of antioxidants
US20070213310A1 (en) * 2002-04-01 2007-09-13 Laszlo Prokai Prodrugs for Use as Ophthalmic Agents
US7300926B2 (en) * 2002-04-01 2007-11-27 University Of Florida Research Foundation, Inc. Steroidal quinols and their use for estrogen replacement therapy
US7186707B2 (en) 2002-04-01 2007-03-06 University Of Florida Prodrugs for use as ophthalmic agents
US20240183014A1 (en) 2022-12-03 2024-06-06 Arthur Craig Reardon High Speed Steel Composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE205169C (enExample) *
US3394153A (en) * 1965-08-18 1968-07-23 Merck & Co Inc Process for the preparation of d, 1-8-dehydroestrone, and intermediates obtained therefrom
US3391170A (en) * 1965-09-21 1968-07-02 Smith 13-alkylogona-1, 3, 5 (10), 9 (11)-tetraenes
US3385872A (en) * 1966-08-29 1968-05-28 Syntex Corp Process for the preparation of 3-hydroxy-19-nor-delta1, 3, 5(10), 9(11)-tetraene steroids
US3471528A (en) * 1968-02-21 1969-10-07 Lilly Co Eli Method for producing delta**9(11) unsaturation in estrone and related compound
US3542819A (en) * 1968-06-11 1970-11-24 American Home Prod Process for preparing 8-isoestrone
US3649621A (en) * 1969-12-19 1972-03-14 American Home Prod Novel 3-cyclopentyl ethers of 13-alkylgon-poly-enes
US3689512A (en) * 1970-10-06 1972-09-05 American Home Prod Novel 3-etherified-1,3,5(10)-triene-steroids and process thereof
DE3014120A1 (de) * 1980-04-12 1981-10-29 Hoechst Ag, 6000 Frankfurt Verfahren zur synthese von oestron bzw. oestronderivaten
DD205169A1 (de) * 1982-05-26 1983-12-21 Adw Ddr Verfahren zur herstellung von 9(11)-dehydro-oestra-1,3,5(10)-trienen
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone

Also Published As

Publication number Publication date
EP0754190B1 (en) 1999-03-03
EP0754190A1 (en) 1997-01-22
HUT76338A (en) 1997-08-28
DE69508068T2 (de) 1999-10-28
US5496814A (en) 1996-03-05
WO1995027724A1 (en) 1995-10-19
JPH09511748A (ja) 1997-11-25
ATE177111T1 (de) 1999-03-15
GR3030185T3 (en) 1999-08-31
TW314468B (enExample) 1997-09-01
IL113178A0 (en) 1995-06-29
US5395831A (en) 1995-03-07
HU9602755D0 (en) 1996-11-28
CN1149298A (zh) 1997-05-07
CA2186486A1 (en) 1995-10-19
KR970702291A (ko) 1997-05-13
DE69508068D1 (de) 1999-04-08
IL113178A (en) 2000-07-26
AU688029B2 (en) 1998-03-05
DK0754190T3 (da) 1999-09-27
AU2242195A (en) 1995-10-30
NZ283951A (en) 1998-07-28
ZA952771B (en) 1996-10-04
US5552395A (en) 1996-09-03

Similar Documents

Publication Publication Date Title
ES2128051T3 (es) Isomero de doble enlace de la equilina, procedente de la isomerizacion acida de la equilina.
PT94504A (pt) Processo para a preparacao de composicoes farmaceuticas aquosas em suspensao para ingredientes activos substancialmente insoluveis em agua
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
EP0911321A3 (en) Compounds for the treatment of osteoporosis
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
CA2234642A1 (en) 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
MY115339A (en) Compositions containing micronized nebivolol
IL91753A0 (en) 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acid,a process for the preparation thereof and pharmaceutical compositions containing them
HUT54144A (en) Process for producing 3-desmethylmevalonic acid derivatives and pharmaceutical compositions comprising same as active ingredient
MX9700564A (es) Derivados de benzoilo y sintesis de los mismos.
WO1998058911A3 (en) Prostaglandin agonists
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
ES8609312A1 (es) Procedimiento para la preparacion de silibinina exenta de isosilibina
AU580822B2 (en) New pyrrolobenzimidazoles, processes for the preparation thereof and pharmaceutical compositions containing them
ATE238986T1 (de) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
IL141325A0 (en) Tan-1057 derivatives
HUT51221A (en) Process for producing pharmaceutical compositions comprising 3-demethyl-4-fluoromevalonic acid derivatives and the active ingredients
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
DE69300453D1 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
HU9602226D0 (en) Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them
IL85425A (en) Anticonvulsant compositions containing substituted benzoyl anilides, some such novel compounds and process for their preparation
AP9801417A0 (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders.
MX9302429A (es) Nuevas tetralonas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
IL110025A0 (en) Phosphonosuccinic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 754190

Country of ref document: ES